Records 1-30 (of 47 Record(s))

Filtered By: Select to fine-tune your search Country Journal Gene Publication Type

Next

Query Trace: Macrophage Activation Syndrome[original query]

---

• Photosynthetically Controlled Spirulina, but Not Solar Spirulina, Inhibits TNF-α Secretion: Potential Implications for COVID-19-Related Cytokine Storm Therapy.
  Tzachor Asaf, et al. Marine biotechnology (New York, N.Y.) 2021 2 0.
  
• Neopterin: A Promising Candidate Biomarker for Severe COVID-19.
  Hailemichael Wasihun, et al. Journal of inflammation research 2021 0 0. 245-251
  
• Comparison of baseline laboratory findings of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis and multisystem inflammatory syndrome in children.
  Aydin Fatma, et al. International journal of rheumatic diseases 2021 2 0.
  
• Immune cartography of macrophage activation syndrome in the COVID-19 era.
  McGonagle Dennis, et al. Nature reviews. Rheumatology 2021 2 0.
  
• Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2.
  Huntington Kelsey E, et al. eLife 2021 1 0.
  
• Immune reactivity during COVID-19: Implications for treatment.
  Napoli Claudio, et al. Immunology letters 2021 1 0.
  
• Case Report: Case Series of Children With Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Switzerland.
  Fouriki Athina, et al. Frontiers in pediatrics 2020 0 0. 594127
  
• Inflammasomes and Childhood Autoimmune Diseases: A Review of Current Knowledge.
  Yang Chin-An, et al. Clinical reviews in allergy & immunology 2020 11 0.
  
• Kawasaki Disease and COVID-19.
  Gkoutzourelas Athanasios, et al. Mediterranean journal of rheumatology 2020 9 0. (Suppl 2) 268-274
  
• Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome.
  Kerget Bugra, et al. Journal of medical virology 2020 10 0.
  
• COVID-19: a Great Mime or a Trigger Event of Autoimmune Manifestations?
  Fatone Maria Celeste, et al. Current rheumatology reviews 2020 10 0.
  
• Covid-19 and kidney injury: Pathophysiology and molecular mechanisms.
  Ahmadian Elham, et al. Reviews in medical virology 2020 10 0. e2176
  
• Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study.
  Webb Brandon J, et al. The Lancet Rheumatology 2020 9 0.
  
• Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19.
  Satis Hasan, et al. Cytokine 2020 9 0. 155302
  
• Preliminary predictive criteria for COVID-19 cytokine storm.
  Caricchio Roberto, et al. Annals of the rheumatic diseases 2020 9 0.
  
• Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view.
  Junior Hany Simon, et al. Jornal de pediatria 2020 9 0.
  
• Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease.
  Zhang Rui Long, et al. Current opinion in pharmacology 2020 9 0. 72-81
  
• Are Serum Interleukin 6 and Surfactant Protein D Levels Associated with the Clinical Course of COVID-19?
  Kerget Bugra, et al. Lung 2020 9 0.
  
• Macrophage responses associated with COVID-19: A pharmacological perspective.
  Booz George W, et al. European journal of pharmacology 2020 9 0. 173547
  
• Practical aspects of targeting IL-6 in COVID-19 disease.
  Calabrese Cassandra, et al. Cleveland Clinic journal of medicine 2020 5 0.
  
• COVID-19 and the immune system.
  Paces J, et al. Physiological research 2020 0 0. (3) 379-388
  
• [Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection].
  Callejas Rubio José Luis, et al. Medicina clinica 2020 0 0. (4) 159-161
  
• Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials.
  Horowitz Richard I, et al. Medical hypotheses 2020 5 0. 109851
  
• The cytokine storm of COVID-19: a spotlight on prevention and protection.
  Pearce Lucie, et al. Expert opinion on therapeutic targets 2020 6 0. 1-8
  
• Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management.
  Nakra Natasha A, et al. Children (Basel, Switzerland) 2020 7 0. (7)
  
• Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study.
  Davies Patrick, et al. The Lancet. Child & adolescent health 2020 0 0. (9) 669-677
  
• Lessons from dermatology about inflammatory responses in Covid-19.
  Criado Paulo Ricardo, et al. Reviews in medical virology 2020 7 0. e2130
  
• COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.
  Perricone Carlo, et al. Immunologic research 2020 0 0. (4) 213-224
  
• Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children.
  Lee Pui Y, et al. The Journal of clinical investigation 2020 7 0.
  
• Immunometabolic Status of COVID-19 Cancer Patients.
  Sica A, et al. Physiological reviews 2020 0 0. (4) 1839-1850
  

Next

---